We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Drug User Fees to Rise Nearly 20 Percent in October
U.S. Drug User Fees to Rise Nearly 20 Percent in October
August 11, 2011
The U.S. user fee for a new drug application requiring clinical data will cost more than $1.8 million beginning Oct. 1 — an increase of 19.42 percent from last fiscal year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor